A Second Look: Discussing the potential of the Optilume Benign Prostatic Hyperplasia Catheter and Balloon system from Urotronic and how it compares to medications from Merck, GSK, and Astellas.

Executed on:Sep 1, 2023 8:00 AM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: New Jersey UrologyGeneral Urologist at New Jersey Urology
Manages over 50 patients a week with Benign Prostatic Hyperplasia

Interview Goal

Reviewing the standard of care for Benign Prostatic Hyperplasia, including the use of medications from Merck, GSK, and Astellas. Talking with an expert about the potential of the Optilume BPH Catheter and Balloon system as an alternative to surgery or medications.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.